ORPHA:1882
Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome
Also known as: ANOTHER syndrome · HEDH syndrome
Publications
682
Trials
0
Interventional, condition-specific
Researchers
1,243
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare, genetic, ectodermal syndrome characterized by the association of hypohidrotic ectodermal (manifesting with the triad of hypohidrosis, anodontia/hypodontia and hypotrichosis) with primary hypothyroidism and respiratory tract ciliary dyskinesia. Patients frequently present urticaria pigmentosa-like skin pigmentation, increased mast cells and melanin depositions in the dermis and severe, recurrent chest infections. There have been no further descriptions in the literature since 1986.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0009150
- MeSH:C565604
- OMIM:225050
- UMLS:C1857052
Additional Mondo synonyms (1)
another syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
682 matched papers (346 in last 10 years) Source
- Phenotype characterisedPresent
15 HPO annotations (e.g. Sparse scalp hair; Short stature; Sparse eyebrow) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
15
Associated phenotypes · MONDO:0009150
- Sparse scalp hair
- Short stature
- Sparse eyebrow
- Lacrimation abnormality
- Hypohidrosis
Showing 5 of 15 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
682
682 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
682 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
346 in the last 10 years · low confidence
Phrase hits: 682 · MeSH hits: 0
Who's working on it?
1,243
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Beales PL4 papers · 2023
Genetics and Genomic Medicine Programme, University College London, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Papers in Europe PMC - 02Schmidts M4 papers · 2023
Center for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg University Faculty of Medicine, Freiburg, Germany.
Papers in Europe PMC - 03Walczak-Sztulpa J4 papers · 2023
Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Papers in Europe PMC - 04Wawrocka A4 papers · 2023
Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Papers in Europe PMC - 05Antony D3 papers · 2023
Center for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg University Faculty of Medicine, Freiburg, Germany.
Papers in Europe PMC - 06Kumar S3 papers · 2023
Department of Cardiology, Westmead Hospital, Sydney, New South Wales, Australia.
Papers in Europe PMC - 07Latos-Bielenska A3 papers · 2020
Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.
Papers in Europe PMC - 08Pazour GJ3 papers · 2023
Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA USA.
Papers in Europe PMC - 09Wu K3 papers · 2023
Human Genetics Department, Radboud University Medical Center Nijmegen and Radboud Institute for Molecular Life Sciences (RIMLS), Nijmegen, The Netherlands.
Papers in Europe PMC - 10Arts HH2 papers · 2020
Department of Human Genetics (855), Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO-Box 9101, 6500 HB Nijmegen, The Netherlands.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 40 · after dedupe 40 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 40 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (40)
- isrctn·ISRCTN17340368·Not yet recruiting·A study testing new HIV treatment options for children and adolescents in Africa
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17701271·Not yet recruiting·129Xenon MRI study of the effects of Mepolizumab on inflammation in the lungs of patients with chronic obstructive pulmonary disease (COPD)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN69014227·Not yet recruiting·Mental practice for arm recovery early after stroke
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN37673511·Recruiting·Evaluation of a cosmetic product in helping to reduce and prevent stretch marks in pregnant women and people experiencing rapid weight changes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN72157798·Recruiting·Developing a vaccine against Bundibugyo ebolavirus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17148628·Not yet recruiting·A study to evaluate the tolerability and the effects on the immune system of a tetanus and diphtheria vaccine which does not need any cold chain distribution or storage
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16150360·Not yet recruiting·Investigating the impact of kefir on metabolic syndrome subjects in an inpatient setting
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15307328·Recruiting·Leigh syndrome roadmap project: a natural history study (UK)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15819396·Recruiting·A Phase I/IIa trial of KJ-103 in solid cancers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN78380445·Recruiting·A clinical trial testing a new treatment called mRNA-4194 for people with Lynch syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14934633·Recruiting·Validation of clinical tests used in physiotherapy diagnostics
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN88133553·Recruiting·A staged dose-finding and challenge/rechallenge study of Staphylococcus aureus nasal colonisation in healthy adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17997560·Recruiting·Long-term assessment of developmental outcomes of newborn babies with sepsis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN89448306·Recruiting·Investigating infection risk and the microbiome in blood cancer patients treated with CD19 CAR-T therapy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN30044928·Recruiting·Economic evaluation of the BabblePlay app intervention to support early vocalising in infants with Down syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13633989·Not yet recruiting·A Phase I/IIa trial of NVG-222 in participants with solid tumours
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15681288·Recruiting·Restoring intestinal symbiosis for efficacy in IBS
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN55506796·Recruiting·Cauda equina syndrome early recognition study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN50499387·Recruiting·Testing a new treatment to prevent severe immune reactions in people with multiple myeloma taking teclistamab
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN96046168·No longer recruiting·Fascial manipulation and thoracolumbar pain
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN23887564·Recruiting·The effect of digital cognitive behavioural therapy for insomnia on physical activity in fibromyalgia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN59688916·No longer recruiting·A study testing whether a traditional herbal medicine can improve constipation and gut health in people with irritable bowel syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16025168·Not yet recruiting·Multicentre study on coaching and point-of-care technologies for patients with myalgic encephalomyelitis/chronic fatigue syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN69516953·Not yet recruiting·Protection against invasive non-typhoidal salmonella disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN30625880·No longer recruiting·Clinical evaluation of the efficacy of a food supplement in improving the regularity of bowel movements
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome" OR "ANOTHER syndrome" OR "HEDH syndrome"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome" OR "ANOTHER syndrome" OR "HEDH syndrome"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (682) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-26T18:23:07.241Z
